| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 02/01/2007 | US20070027308 Expressed sequence tags and encoded human proteins |
| 02/01/2007 | US20070027307 Microwave method for preparing radiolabelled gallium complexes |
| 02/01/2007 | US20070027306 With improved shelf life and storage stability; expression vectors and host cells; therapeutic proteins are chemically or genetically fused to albumin; hypoglycemic agents, analgesics; retinopathy, cardiovascular disease, obesity, renal disease, neuropathy |
| 02/01/2007 | US20070027305 Method and system for in vitro protein folding |
| 02/01/2007 | US20070027304 Mammalian IAP gene family, primers, probes and detection methods |
| 02/01/2007 | US20070027303 Metal chelate complexes immobilized on solid supports for peptide preparation |
| 02/01/2007 | US20070027215 Nuclear receptor ligands and ligand binding domains |
| 02/01/2007 | US20070027091 Therapy of obesity, diabetes, bulimia, atherosclerosis, hypertension, diabetes, type 2 diabetes, impaired glucose tolerance (IGT), dyspilidemia, coronary heart disease, gallbladder disease, gall stone, osteoarthritis, cancer, sexual dysfunction, and the risk of premature death; cyclic peptides |
| 02/01/2007 | US20070027089 Inhibitors of amyloid precursor protein processing |
| 02/01/2007 | US20070027086 use for treatment of medical and veterinary conditions which can be influenced by the MC1-receptor; act as antiinflammatory and immunomodulatory agent; inhibit the production of nitric oxide (NO) |
| 02/01/2007 | US20070027084 Novel Integrin Ligand ITGL-TSP |
| 02/01/2007 | US20070027078 Isolated proteins from a traditional Chinese medicine Yuzhu and use thereof |
| 02/01/2007 | US20070027074 Peptide dimer bonded to polyethylene glycol through amide groups; insufficient or defective red blood cell production |
| 02/01/2007 | US20070027073 Long-acting derivatives of pyy agonists |
| 02/01/2007 | US20070027069 Glucan-protein complex extracted from grifola (Maitake) |
| 02/01/2007 | US20070027068 Forming a convalent conjugate of a peptide, EPO, removing X2 or a saccharyl subunit thereof from peptide forming a truncated glycan; contacting truncated glycan with glycosyltransferase and modified sugar donor under conditions suitable for glycosyltransferase to transfer a modified sugar moiety |
| 02/01/2007 | US20070026521 Polynucleotides for use in recombinant adeno-associated virus virion production |
| 02/01/2007 | US20070026502 Specificity exchangers that redirect antibodies to a pathogen |
| 02/01/2007 | US20070026501 Immunogen, composition for immulogical use and process for producing antibody using the same |
| 02/01/2007 | US20070026500 Crystalline Neutrokine-alpha protein, method of preparation thereof, and method of use thereof |
| 02/01/2007 | US20070026499 nucleotide or DNA constructs comprising expression cassettes comprising promoters operably linked to transgene open reading frames, used in protein production, diagnostics, transgenic plants and animals and the therapeutic field |
| 02/01/2007 | US20070026498 Nucleic acid sequences having gene transcription regulatory qualities |
| 02/01/2007 | US20070026497 Method for controlling metallophosphate precipitation in high cell density fermentations |
| 02/01/2007 | US20070026496 Process for Producing Polypeptides |
| 02/01/2007 | US20070026495 Novel Integrin Ligand ITGL-TSP |
| 02/01/2007 | US20070026494 Mammalian IAP gene family, primers, probes and detection methods |
| 02/01/2007 | US20070026492 Expression of G protein-coupled receptors with altered ligand binding and/or coupling properties |
| 02/01/2007 | US20070026489 Vegetarian protein a preparation and methods thereof |
| 02/01/2007 | US20070026488 Biosynthesis of bryostatins by polyketide synthases (PKS) |
| 02/01/2007 | US20070026487 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/01/2007 | US20070026486 chimera; nuclear factor kappa beta; vectors, host cell; gene therapy; pharmacokinetics |
| 02/01/2007 | US20070026485 Glycopegylation methods and proteins/peptides produced by the methods |
| 02/01/2007 | US20070026474 provides highly purified polypeptides and antibodies for use in accurate assays |
| 02/01/2007 | US20070026470 Mammalian IAP gene family, primers, probes and detection methods |
| 02/01/2007 | US20070026464 Biologically active synthetic thyrotropin and cloned gene for producing same |
| 02/01/2007 | US20070026463 Compositions and methods of mutant Nogo-66 domain proteins |
| 02/01/2007 | US20070026462 bacteriophage comprising a promoter operably linked to a nucleic acid sequence encoding a GAS1 secretion signal peptide; for generating an immunoglobulin variable domain polypeptide library and for the generation of single domain antibodies themselves |
| 02/01/2007 | US20070026457 Screening method |
| 02/01/2007 | US20070026450 Methods for the treatment of carcinoma |
| 02/01/2007 | US20070026449 Novel human sodium-dependent phosphate cotransporter |
| 02/01/2007 | US20070026448 vectors, host cells, and recombinant and synthetic methods for producing said polypeptides; polypeptide has N-formyl peptide receptor activity |
| 02/01/2007 | US20070026446 Enhanced genome copy number, and capacity for expression and/or secretion of proteins and secondary metabolites |
| 02/01/2007 | US20070026445 Novel steroid-activated nuclear receptors and uses therefor |
| 02/01/2007 | US20070026437 Novel BMP products |
| 02/01/2007 | US20070026425 Hepatitis C virus Non-structural NS3/4A fusion gene |
| 02/01/2007 | US20070026422 Vaccine-induced hepatitis B viral strain and uses thereof |
| 02/01/2007 | US20070026409 Nucleic acid and amino acid sequences involved in pain |
| 02/01/2007 | US20070026396 Peptides directed against antibodies, which cause cold-intolerance, and the use thereof |
| 02/01/2007 | US20070026395 Human cancer-relating genes, the products encoded thereby and applications thereof |
| 02/01/2007 | US20070026393 Detection of variations in the dna methylation profile |
| 02/01/2007 | US20070026384 Detection of transmembrane potentials by optical methods |
| 02/01/2007 | US20070026088 a powder extracted from hardened antlers which contains 0.5 ng of insulin and insulin-like growth factor-I in the quantity of 18 ng per 1 g using ion exchange chromatography; hypoglycemic agent |
| 02/01/2007 | US20070026076 Molecular vaccines employing nucleic acid encoding anti-apoptotic proteins |
| 02/01/2007 | US20070026022 Recombinant adenylate cyclase toxin of Bordetella induces T cell responses against tumoral antigens |
| 02/01/2007 | US20070026021 Proteins from Neisseria meningitidis, including the amino acid sequences and the corresponding nucleotide sequences; proteins are predicted to be useful antigens for vaccines and/or diagnostics; provides Neisserial DNA sequences which encode proteins that are antigenic or immunogenic |
| 02/01/2007 | US20070026018 Methods for treating, preventing and diagnosing Helicobacter infection |
| 02/01/2007 | US20070026017 Brachyspira pilosicoli 72kda outer-membrane protein and diagnostic and therapeutic uses thereof |
| 02/01/2007 | US20070026016 site-directed mutagenesis; immunogens; vaccines |
| 02/01/2007 | US20070026013 Albumin fusion proteins |
| 02/01/2007 | US20070026012 Compositions and methods for monitoring and altering protein folding and solubility |
| 02/01/2007 | US20070026011 Sdr proteins from staphylococcus capitis and their use in preventing and treating infections |
| 02/01/2007 | US20070026010 Purification process for bacterial cytolysin |
| 02/01/2007 | US20070026009 Using influenza virus peptide as tool in diagnosis and treatment of viral diseases |
| 02/01/2007 | US20070026007 treatment of conditions characterized by a need to modulate migratory-cell movement associated with specific sites in a subject; isolating a stromal-cell-derived fugetactic agent |
| 02/01/2007 | US20070026003 Monoclonal antibodies; HCV enveloped subviral or purified HCV enveloped complete viral particles; hybridoma |
| 02/01/2007 | US20070026001 APO-2 ligand-anti-her-2 antibody synergism |
| 02/01/2007 | US20070025998 Methods for enhancing the efficacy of cancer therapy |
| 02/01/2007 | US20070025993 Tek antagonists |
| 02/01/2007 | US20070025984 Treatment of ulcerative colitis with tropomyosin isoforms and monoclonal antibodies to tropomyosin isoforms |
| 02/01/2007 | US20070025983 Compounds capable of inhibiting HIV-1 infection |
| 02/01/2007 | US20070025971 Substances causing differentiation |
| 02/01/2007 | US20070025968 Methods for selecting and producing T cell peptide epitopes and vaccines incorporating said selected epitopes |
| 02/01/2007 | US20070025966 With a sugar or polyethylene glycol; improved antiviral and immunomodulatory efficacy; HIV and hepatitis C vaccines |
| 02/01/2007 | US20070025962 Interleukin-8 homologous polypeptides and therapeutic uses thereof |
| 02/01/2007 | US20070025959 Adjuvant combination formulations |
| 02/01/2007 | US20070025913 Immunoglobulin which specifically binds endothelial cell-specific polypeptides; for use as evaluative tool in immunodiagnostic and drug efficacy studies |
| 02/01/2007 | US20070022547 Coloring compositions with peptide-based dispersants and binders |
| 02/01/2007 | DE102005035888A1 New transgenic cereal plants that express the sweetener thaumatin, also related nucleic acid, protein, vectors and malted or milled products for use in foods |
| 02/01/2007 | DE10196565B4 Rekombinantes Human-Parathyroidhormon erzeugender Hefe-Transformant und Verfahren zur Herstellung des Hormons Recombinant human parathyroid hormone-producing yeast transformant and methods for producing the hormone |
| 02/01/2007 | CA2616805A1 Targeting-enhanced activation of galectins |
| 02/01/2007 | CA2616778A1 Tight junction modulating peptide components for enhancing mucosal delivery of therapeutic agents |
| 02/01/2007 | CA2615777A1 Tfpi fragments as anti-microbial agents |
| 02/01/2007 | CA2615710A1 Sensitization of immune system against haptenized melanoma antigens |
| 02/01/2007 | CA2614082A1 Compositions and methods for protein deaggregation |
| 02/01/2007 | CA2614039A1 Compositions and methods of treating disease with fgfr fusion proteins |
| 01/31/2007 | EP1748078A2 Methods, kits and compositions of combination oligomers |
| 01/31/2007 | EP1748075A1 Recombinant chemokine-antigen vaccine |
| 01/31/2007 | EP1748069A1 Follistatin mutant polypeptide |
| 01/31/2007 | EP1748065A2 Cell cycle progression proteins |
| 01/31/2007 | EP1748050A1 Targeting-enhanced activation of galectins |
| 01/31/2007 | EP1747784A1 Target gene mimitin of myc |
| 01/31/2007 | EP1747291A2 Haplotype markers and methods of using the same to determine response to treatment |
| 01/31/2007 | EP1747287A2 Genotoxic testing |
| 01/31/2007 | EP1747280A2 Methods for reducing or eliminating alpha-mannosidase resistant glycans in the production of glycoproteins |
| 01/31/2007 | EP1747273A2 Gene-cassette for enhancement of protein production |
| 01/31/2007 | EP1747236A1 Nectin 4(n4) as a marker for cancer prognosis |
| 01/31/2007 | EP1747235A1 Crystal structure of human proliferating cell nuclear antigen (pcna) and uses thereof |
| 01/31/2007 | EP1747234A1 A protein involved in cancer |
| 01/31/2007 | EP1747233A1 Compounds for specific viral target |
| 01/31/2007 | EP1747228A2 Novel compositions and methods in cancer |